All Type of News
KFDA to overhaul functional health food codex.
To provide general consumers with a diverse option to get functional health supplement foods and to promote the functional health supplement food industries, the KFDA is earnestly considering a substantial level of ex...
AstraZeneca Korea to hold five-finger heart campaignAstraZeneca Korea will hold its five-finger campaign to protect a heart for ordinary people and hypertensive patients to conduct an active publicity campaign of Atacand (candesa...
|
Government to get tougher in drug approval process
The government plans to strengthen a system to suspend the approval process of a generic drug when the original developer files a complaint about patent violation against a generic maker that applies for product appro...
Korea drug patents still at lower level on its quality.
The drug patents of Korea showed a remarkable progress in its registration volumes over the world but still remained on an infant phase in terms of its quality.
The Korea Patent Office report titled "2006 patent st...
State-run medical institutions to prescribe drugs by generic name in September
Health and Welfare Minister Byun Jae-jin reaffirmed a plan that the National Medical Center would introduce the controversial system of prescribing medicines by generic name from next month, regardless of vehement opp...
Seroquel as top therapy for manic depressive psychosis.
AstraZeneca (AZ) Korea said on Aug. 13 that Seroquel (quetiapine fumarate) ranked the top product in the treatment of the manic depressive psychosis in Korea.
Seroquel was approved by the US FDA in 2006 for the in...
Abbott's new cancer agent has promising results in Phase 1 trial
Abbott Laboratories' cancer drug proved to be promising in its Phase I study after it showed signs of shrinking lung tumors, said a doctor who performed an earlier trial in Singapore.
The Phase II trial of the medi...
Novel blood sugar biosensors to bring medical revolution
"New biosensor technology for monitoring glucose levels in people with diabetes is moving ahead rapidly as a growing number of Korean biopharmaceutical companies are struggling to develop tailored systems of combining...
Dong-A to commit $68 mil. worth of export sales to Russia and east Europe.Dong-A made an export sales agreement for the prescription and bio drugs with 5 companies in Turkey, Russia and Ukraine at the total U$68 mil. for 5 years to come. The total 7 p...
|
LG Life Science to distribute Sancuso exclusively.
LG Life Science announced on Aug. 10 that the company made a technical licence agreement with ProStrakan Group, a UK pharmaceutical company for an exclusive distribution of Sancuso, a patch form of anti-vomiting drug,...
